Fig. 6

Immunofluorescent study for the detection of cleaved caspase-3 in HepG2 cells (a-d) or primary mouse hepatocytes (f-i) at 2–24 h after co-incubation of activated and coagulated human or mouse platelets with or without the treatment of 300 µM of Kp7-6, a Fas/FasL antagonist. (e and j) The quantitative data of cleaved caspase-3 fluorescence intensity. Data are expressed as mean ± SE (n = 3). **, p < 0.01.